Perelman School of Medicine

Plasma Ap0A1 Associates with Age at Onset and Motor Severity in Early Parkinson’s Disease Patients, Penn Medicine Researchers Find

Building on previous research showing that plasma Apolipoprotein A1 (ApoA1) may be a useful biomarker for Parkinson’s disease, researchers from the Perelman School of Medicine at the University of Pennsylvania have replicated these findings in approximately 1,000 patients from across the world, upholding their

Lee-Ann Donegan



In the News


CNN

Vaping immediately affects vascular health and oxygen levels, study shows, even without nicotine

Research published by Marianne Nabbout while a resident at the Perelman School of Medicine finds that vaping has an immediate effect on blood vessels even if an e-cigarette doesn’t contain nicotine.

FULL STORY →



Fox 29 (Philadelphia)

Former patient gives thanks to PA hospital staff after surviving coma, COVID-19 battle

A former COVID patient who spent six months in a coma returned to thank the Penn Medicine team that contributed to his survival, including Megan Carr-Lettieri.

FULL STORY →



Philadelphia Inquirer

Is there a chemical link to memory loss? Penn researchers get $11M to study dementia causes

The National Institutes of Health have awarded $11 million to Aimin Chen of the Perelman School of Medicine to study the link between chemical exposures and dementia.

FULL STORY →



Philadelphia Inquirer

COVID patient who survived coma reunites with Penn care team

A COVID patient who survived his coma recently reunited with the Penn Medicine care team that helped save his life, including Jennifer Olenik of the Perelman School of Medicine.

FULL STORY →



Forbes

Insomnia may be more common than you think. Here’s what to know

According to Penn Medicine, about 1 in 4 Americans experiences difficulty with sleep each year.

FULL STORY →